Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, by adding a state-of-the-art spray drying suite. This technology allows for the efficient processing of complex molecules and peptides, improving bioavailability and manufacturing safety.
MUMBAI, India , Aug. 4, 2026 /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has launched a state-of-the-art spray drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India. This strategic expansion enables PPS to address the complex formulation challenges associated with peptides and other complex molecules and support the growing demand for these innovative molecules.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in